| 07/16/2026 5:08 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2026 3:54 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 3:10 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/15/2026 3:13 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/16/2026 4:53 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 5:02 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:30 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2026 5:29 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:31 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:32 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:34 PM | Cain Wettan Keeley M (2110603) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GILD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/11/2026 5:35 PM | Berger Dietmar (1739515) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 5:04 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 3:45 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/27/2026 7:55 PM | ASSEMBLY BIOSCIENCES, INC. (1426800) Issuer Gilead Sciences (882095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 7:51 PM | ASSEMBLY BIOSCIENCES, INC. (1426800) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 05/20/2026 3:15 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:45 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 4:50 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:15 PM | Gilead Sciences (882095) Filer | Form 424B5 | |
| 05/14/2026 4:11 PM | Gilead Sciences (882095) Subject | Form FWP | |
| 05/14/2026 7:46 AM | Gilead Sciences (882095) Filer | Form 424B5 | |
| 05/08/2026 4:00 PM | Gilead Sciences (882095) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/07/2026 4:12 PM | Gilead Sciences (882095) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 4:13 PM | Gilead Sciences (882095) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/07/2026 3:03 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 3:31 PM | Gilead Sciences (882095) Issuer Horning Sandra (1638709) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:36 PM | BARTON JACQUELINE K (1183680) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:19 PM | Gilead Sciences (882095) Issuer Kramer Kelly A. (1629885) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:20 PM | Gilead Sciences (882095) Issuer MANWANI HARISH (1527726) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:05 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 5:41 PM | Gilead Sciences (882095) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 4:53 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/28/2026 8:13 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 04/28/2026 7:53 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 04/28/2026 7:56 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:00 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 04/16/2026 5:40 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 5:41 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:12 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/15/2026 3:08 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Oxford Club Analyst’s Urgent AI Warning (Ad) Alexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warning for AI investors - and a specific prediction about what the number-one investment of the next decade will be.
Green started his career on Wall Street four decades ago and retired in his 40s. He believes a major shift in the AI trade is coming - and that most investors won't hear about it until it's too late. Watch Green's private presentation and see his full AI prediction |
| 04/01/2026 3:34 PM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 03/30/2026 4:59 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 3:03 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:40 PM | Gilead Sciences (882095) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/17/2026 5:56 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 5:14 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:45 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:24 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:46 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 1:49 PM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-C | |
| 02/23/2026 5:46 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 5:48 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-C | |
| 02/23/2026 5:51 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D | |
| 02/18/2026 4:11 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 4:31 PM | Gilead Sciences (882095) Reporting Xilio Therapeutics, Inc. (1840233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 6:26 PM | Cain Wettan Keeley M (2110603) Reporting Gilead Sciences (882095) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/06/2026 3:22 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:49 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:51 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:46 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 12:23 PM | FMR LLC (315066) Filed by Gilead Sciences (882095) Subject | Form SCHEDULE 13G | |
| 01/29/2026 4:23 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 6:29 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 3:03 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:32 PM | Gilead Sciences (882095) Subject Telman Deborah H (1860008) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 3:26 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:01 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/16/2026 5:10 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/16/2026 5:18 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:01 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/15/2026 3:02 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/05/2026 4:56 PM | Berger Dietmar (1739515) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 3:23 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:31 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:12 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:04 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 3:04 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 7:38 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 7:40 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 5:25 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 5:11 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 3:36 PM | Gilead Sciences (882095) Reporting Xilio Therapeutics, Inc. (1840233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 12:02 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/28/2025 12:05 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/26/2025 3:16 PM | Gilead Sciences (882095) Subject Kramer Kelly A. (1629885) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/19/2025 7:30 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/18/2025 6:00 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 5:51 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:05 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/17/2025 3:06 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Universal Basic Income ALREADY exists (Ad) Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal basic income. His Patriot Income Plan - funded by 14 partnerships controlling America's critical oil and gas infrastructure - already pays 10% a year with 42 payouts annually.
Some investors are already collecting $4,800 a month. One has built income up to $25,000 a month. These partnerships have averaged 20% annual gains since 2020, with no U.S. tax dollars involved.
The next payout drops in days. Click here to enroll in the Patriot Income Plan and see full details |
| 11/13/2025 6:36 PM | Gilead Sciences (882095) Issuer Telman Deborah H (1860008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 4:07 PM | Gilead Sciences (882095) Subject Wilfong Diane E. (1374988) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 3:44 PM | Gilead Sciences (882095) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 11/05/2025 4:19 PM | Arcus Biosciences, Inc. (1724521) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 10/29/2025 3:14 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2025 4:47 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/27/2025 6:43 PM | Gilead Sciences (882095) Issuer Telman Deborah H (1860008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 8:35 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 8:28 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |